Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
35
RSPH Quote, Financials, Valuation and Earnings
Last price:
$29.62
Seasonality move
:
2.86%
Day range:
$29.38 - $29.62
52-week range:
$28.92 - $32.85
Dividend yield:
0.7%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
38.2K
Avg. volume:
86.1K
1-year change:
0.1%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$29.62 | -- | -- | -- | $0.06 | 0.7% | -- |
|
BBH
VanEck Biotech ETF
|
$158.96 | -- | -- | -- | $1.25 | 0.79% | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
$27.21 | -- | -- | -- | $0.13 | 1.65% | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
$66.56 | -- | -- | -- | $0.21 | 1.71% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$48.49 | -- | -- | -- | $0.10 | 0.85% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$83.00 | -- | -- | -- | $0.22 | 0.97% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 1.335 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 1.127 | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | 1.073 | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | 1.040 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | 1.288 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.832 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
Invesco S&P 500 Eql Wght Health Care ETF vs. Competitors
-
Which has Higher Returns RSPH or BBH?
VanEck Biotech ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About RSPH or BBH?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than VanEck Biotech ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is RSPH or BBH More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.303%.
-
Which is a Better Dividend Stock RSPH or BBH?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. VanEck Biotech ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $1.25 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or BBH?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns RSPH or FTXH?
First Trust Nasdaq Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat First Trust Nasdaq Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -
What do Analysts Say About RSPH or FTXH?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than First Trust Nasdaq Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than First Trust Nasdaq Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 -
Is RSPH or FTXH More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.658, suggesting its less volatile than the S&P 500 by 34.157%.
-
Which is a Better Dividend Stock RSPH or FTXH?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. First Trust Nasdaq Pharmaceuticals ETF offers a yield of 1.65% to investors and pays a quarterly dividend of $0.13 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. First Trust Nasdaq Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or FTXH?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than First Trust Nasdaq Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while First Trust Nasdaq Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for First Trust Nasdaq Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns RSPH or IHE?
iShares US Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- -
What do Analysts Say About RSPH or IHE?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than iShares US Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 IHEiShares US Pharmaceuticals ETF0 0 0 -
Is RSPH or IHE More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.656, suggesting its less volatile than the S&P 500 by 34.431%.
-
Which is a Better Dividend Stock RSPH or IHE?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. iShares US Pharmaceuticals ETF offers a yield of 1.71% to investors and pays a quarterly dividend of $0.21 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or IHE?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- IHEiShares US Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns RSPH or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About RSPH or IHF?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is RSPH or IHF More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.765, suggesting its less volatile than the S&P 500 by 23.516%.
-
Which is a Better Dividend Stock RSPH or IHF?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. iShares US Healthcare Providers ETF offers a yield of 0.85% to investors and pays a quarterly dividend of $0.10 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or IHF?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
-
Which has Higher Returns RSPH or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is RSPH or PJP More Risky?
Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.863, which suggesting that the stock is 13.707% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.580, suggesting its less volatile than the S&P 500 by 42.037%.
-
Which is a Better Dividend Stock RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.7%. Invesco Pharmaceuticals ETF offers a yield of 0.97% to investors and pays a quarterly dividend of $0.22 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RSPH or PJP?
Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
